Facing The Drug Launch Challenge As A New CEO
As a CEO of a pharma or biotech company, getting your products to market is one of, if not the,
As a CEO of a pharma or biotech company, getting your products to market is one of, if not the,
Corporates are wielding M&A to scoop up the tech they need in order to keep up with strict rules and regulations
Temporary structure is a cost-effective alternative to phased construction in Nacogdoches County
PERSPECTIVES ON ACCESS Read the article as it appears on PharmaLive. As the number of rare disease drugs on the
Real Estate Capital offers candid, one-on-one conversations with some of the most influential people in commercial real estate. Hosted by Nancy
Award recognizes Acrow’s continued growth in international markets PARSIPPANY, N.J., June 06, 2023 (GLOBE NEWSWIRE) — Acrow, a leading international